Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PALI similar filings
- 17 Oct 22 Departure of Directors or Certain Officers
- 14 Oct 22 Entry into a Material Definitive Agreement
- 7 Oct 22 Submission of Matters to a Vote of Security Holders
- 26 Sep 22 Changes in Registrant's Certifying Accountant
- 15 Sep 22 Cost Associated with Exit or Disposal Activities
- 16 Aug 22 Palisade Bio Announces Pricing of $12 Million Upsized Underwritten Public Offering
- 15 Aug 22 Amendments to Articles of Incorporation or Bylaws
Filing view
External links
Exhibit 16.1
September 26, 2022
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sir/Madam:
We have read Item 4.01(a) of Palisade Bio Inc.’s Form 8-K dated September 26, 2022, and we agree with the statements made therein. We have no basis on which to agree or disagree with the statements made in Item 4.01(b).
Yours truly,
/s/ BDO USA, LLP